Friday, May 27, 2022

Medisca Drives Worldwide Access to Thyroid through Distribution License with SUANFARMA

 MONTREAL-Friday 27 May 2022 [ AETOS Wire ]


(BUSINESS WIRE) -- On March 16, 2022, Medisca, a global supplier of pharmaceutical ingredients and equipment, entered into an exclusive agreement with SUANFARMA, a European-based manufacturer and distributor of pharmaceutical ingredients, for the global supply and distribution of Thyroid Powder, USP, by leveraging its exclusive partnership with pharmaceutical manufacturer, Sichuan Deebio Pharmaceutical Co., Ltd (Deebio).


“Partnering with Deebio in June 2021 was a huge milestone for the pharmaceutical compounding industry as it allowed us to secure and stabilize the supply of high quality Thyroid Powder for the US market,” said Panagiota Danopoulos, Senior Vice President of Global Strategy & Innovation at Medisca.


“After going to market, we immediately realized that the demand for Thyroid Powder extended outside of our usual distribution channels to compounding pharmacies,” continued Danopoulos. “And we had the capacity to upscale supply to make this critical ingredient accessible to various markets, channels, and patients across the globe. A need we will now meet through our partnership with SUANFARMA.”


Already an existing partner and supplier of ingredients to Medisca, striking this agreement with SUANFARMA involved reinforcing a well-established symbiotic relationship between two companies committed to world-class quality, service, and price.


“The quality standards set, transparency created, and commitment established between Medisca and Deebio, is what gave us the confidence in choosing Medisca as our primary supplier of Thyroid Powder, USP,” said Gustavo Adolfo Porras, Head of Sales, North America at SUANFARMA. “We look forward to continuing to expand our strong relationship with Medisca.”


For Medisca, the mission is simple – to drive forward worldwide access to qualified products by developing strategic partnerships aligned to the same standards of quality, consistency, and affordability that define Medisca.


Medisca remains the leading supplier of Thyroid Powder, USP to compounding pharmacies. Available for purchase online here.


SUANFARMA will now streamline distribution to Medisca’s supply of Thyroid Powder, USP to other channels and markets.


About MEDISCA®


MEDISCA is a global leader in healthcare with well-established footings in pharmaceutical compounding and advancements in scientific labs, cosmetics, other healthcare industries. For 30+ years, MEDISCA has been serving pharmacies and allied healthcare institutions with cutting-edge offerings and passionate commitment, developing a worldwide network dedicated to personalized medicine. Through genuine relationships, worry-free experiences, convenient processes, and strategic global partnerships, MEDISCA provides top-quality and innovative products, industry-leading services, and world-class support systems. For more information visit www.medisca.com and follow us on Twitter at @medisca.


About SUANFARMA


SUANFARMA founded in 1993, is a B2B life science partner specialized in the development, production, and commercialization of ingredients for the pharmaceutical, veterinary and nutraceutical industries. Our facilities comply with the highest existing regulations in the pharmaceutical industry. With the support of a consolidated and strong commercial network with 12 local offices placed strategically around the world, SUANFARMA provides its services to more than 3.000 active customers in over 70 countries. For more information, visit www.suanfarma.com.


View source version on businesswire.com: https://www.businesswire.com/news/home/20220526005571/en/


Contacts

Panagiota Danopoulos

SVP Global Strategy & Innovation at Medisca

www.medisca.com

1-800-665-6334


OnlyFans Founder Launching Celebrity Trading Card Platform, Zoop, Backed by Polygon

Polygon, the top global blockchain ecosystem, invests in new digital trading card platform created for celebrities, led by former OnlyFans executives


NEW YORK-Friday 27 May 2022 [ AETOS Wire ]


(BUSINESS WIRE) -- Led by a robust team of Web3 developers and former OnlyFans executives, Zoop is set to launch their digital collectable trading platform powered by Polygon, the decentralized Ethereum scaling ecosystem. Zoop’s platform allows users to buy, sell, collect and trade 3D digital playing cards of their favorite celebrities.


On Zoop, fans can acquire officially licensed, limited edition digital cards, and are able to sell and trade them in a secondary market.


“Zoop is the trusted home for authentic celebrity card drops, enabling all fans, regardless of their technical expertise, to participate in the web3.0 space. We hold users' hands as they compete in acquiring digital collectables in the auction process, show off their holdings to friends and ‘collect-to-connect’ with their favorite celebrities of today and tomorrow. Zoop provides access to communities based on the cards users own, and rewards points to users for their interactions with each other and within these communities. We are excited to be launching Summer 2022,” says RJ Phillips, Founder and co-CEO of Zoop. “It’s a win for the celebrities, creates excitement for the fans and a new way for brands to connect with their customers,” he said.


Zoop is capitalizing on the booming blockchain gamification market, which grew to a $40 billion industry in 2021. And, by 2026, the industry is predicted to grow to $147 billion. By opening up the platform and combining it with today’s influencer-driven creator economy, Zoop’s app allows fans to collect 3D digital trading cards from their favorite influencers and celebrities, fostering a closer connection between fan and influencer. Fans can buy, sell, and trade cards, as well as compete in competitions and challenges to gain points, unlocking special rewards including access to like- minded communities. Zoop’s inclusive ecosystem is creating value for digital trading cards by enabling a fully transparent leaderboard.


The Zoop team will be led by co-CEOs Tim Stokely, tech Entrepreneur and founder of OnlyFans, and RJ Phillips. Tim, who will be joining the team in time for the launch this summer, brings extensive knowledge of the creator economy and a proven track record in building a true tech unicorn while RJ’s expertise in growth and scaling make for the perfect leadership team. Together, Tim and RJ plan to leverage their past career successes and knowledge of the creator economy to ultimately scale Zoop into a global digital trading card ecosystem that drives value for both creators and fans alike.


As a precursor to its initial launch, Zoop is offering a limited number of pre-launch Priority Passes (PP), which reward the earlier adopters with a host of perks, both in-app and real-life, in addition to exclusive airdrops only for PP holders. The first batch of these Priority Passes are available now at mint.zoopcards.com.


Zoop will be building its digital marketplace on the globally recognized Polygon blockchain network. Like Zoop, Polygon believes in Web3 for all, making them an ideal partner and blockchain of choice for the Zoop platform. Their low transaction costs and high security standard make card trading on Zoop safe and accessible for all. Additionally, Polygon’s sustainability commitment to make all their NFTs carbon-negative by the end of 2022 was another important factor for Zoop.


“We're delighted to be working with the Zoop team as they build out their platform on Polygon. Zoop aligns with our mission to bring Web3 technologies to a much broader demographic, and allowing fans to connect to their favorite celebrities via Polygon is another step towards this goal," said Michael Blank, COO of Polygon Studios, who has been providing Zoop with a suite of services such as technical support, Web3 game design and distribution, asset expansion and more.


Zoop's announcement comes just weeks after Instagram began minting their non-fungible tokens (NFTs) on Polygon's carbon-neutral network as well.


About Zoop


Zoop is building an entire ecosystem based on officially licensed celebrity digital trading cards. Fans are easily able to buy, sell, trade and collect the celebrities and influencers they idolize and admire through cutting edge blockchain technology. On Zoop, fans can build out their card collections and earn fan rewards with exclusive celebrity experiences whilst forging communities of like-minded collectors. Zoop cards garner authenticity through official partnerships with an unrivaled roster of celebrities and brands onboard. To learn more visit www.zoopcards.com.


Website | Twitter | Telegram | LinkedIn | Discord | Instagram | Facebook | Mint Page | Support Twitter | Medium | Tim’s Instagram | RJ’s Instagram


About Polygon


Polygon is the leading platform for Ethereum scaling and infrastructure development. Its growing suite of products offers developers easy access to all major scaling and infrastructure solutions: L2 solutions (ZK Rollups and Optimistic Rollups), sidechains, hybrid solutions, stand-alone and enterprise chains, data availability solutions, and more. Polygon’s scaling solutions have seen widespread adoption with 19,000+ applications hosted, 3.4B+ total transactions processed, ~135M+ unique user addresses, and $5B+ in assets secured.


If you're an Ethereum Developer, you're already a Polygon developer! Leverage Polygon’s fast and secure txns for your dApp, get started here.


Website | Twitter | Ecosystem Twitter | Developer Twitter | Studios Twitter | Telegram | LinkedIn | Reddit | Discord | Instagram | Facebook


About Polygon Studios


Polygon Studios aims to be the home of the most popular blockchain projects in the world. The Polygon Studios team is focused on supporting developers building decentralized apps on Polygon by providing Web2 and Web3 teams with a suite of services such as developer support, partnership, strategy, go-to-market, and technical integrations. Polygon Studios supports projects from OpenSea to Prada, from Adidas to Draft Kings and Decentral Games to Ubisoft.


Twitter | Facebook | Instagram | Telegram | Tiktok | LinkedIn


DISCLAIMER: Except where otherwise noted, the information contained in this release is as of May 26, 2022. We assume no obligation to update any forward-looking statements contained in this release as a result of new information or future events or developments. We cannot guarantee that any forward-looking statement will be realized. Should known or unknown risks or uncertainties materialize or should underlying assumptions prove inaccurate, actual results could vary materially from those anticipated, estimated or projected. Readers are cautioned not to put undue reliance on forward-looking statements.


View source version on businesswire.com: https://www.businesswire.com/news/home/20220526005159/en/


Contacts

Media:

Bryson Greene

zoop@bevelpr.com


Polygon Media:

Katie Olver

polygon@cryptolandpr.com

Trading Central wins at the Technical Analyst Awards

 OTTAWA, Ontario & PARIS-Friday 27 May 2022 [ AETOS Wire ]


(BUSINESS WIRE) -- The Technical Analyst Awards recognize the best in market research, financial data, software and artificial intelligence. At the 2022 edition, industry peers voted Trading Central a winner in three categories: Best AI Product, Most Innovative New Product & Best Multi-Asset Data Provider.


Trading Central’s suite of embeddable apps & APIs power the world’s leading online broker platforms to support investors and active traders throughout their decision making journey. We’re proud to be recognized for our relentless efforts to challenge ourselves, innovate and disrupt the industry.


TC Market Buzz® for Best AI Product 

Read less, know more


TC Market Buzz leverages Artificial Intelligence to make sense of the millions of news headlines, social media posts and articles posted online every day. It replaces static headlines with simple, compelling and informative data visualizations.


Users can:


Identify what instruments are buzzing based on news volume


View the most discussed topics for an instrument


Fact check stories with articles from leading news providers


TC Fundamental Insight® for Most Innovative New Product 

The future of fundamentals


Fundamental investors have to digest mountains of corporate information published by listed companies. Fundamental Insight offers simple interpretations of complex financial data to help users make smart decisions.


TC Quantamental Rating®: A high level view of how a stock is performing.


Target Price: A projection of where a stock could land in 12 months.


Nowcasting: A macroeconomic indicator for insights on asset allocation, sector rotation and price movements.


Trading Central for Best Multi-Asset Data Provider 

One-stop-shop for investment decision support


Trading Central analytics are powerful tools for customer acquisition, engagement and retention. Their suite supports users of all skill-levels who are trading stocks, currencies, cryptos, commodities & more. Trading Central research helps investors find and validate opportunities, time trades, learn about the financial markets, and manage risk.


Alain Pellier, CEO of Trading Central, says, “These awards highlight new products and analytical proficiencies launched by Trading Central over the past year. In our efforts to support brokerage businesses as a one-stop-shop for investment decision support, we’re proud to be recognized by the Technical Analyst Awards as a leader in this ever-changing industry.”


Trading Central recently won in the Financial Research & Data Innovation category at the Fintech Breakthrough Awards.


Learn about Trading Central’s solutions.


View source version on businesswire.com: https://www.businesswire.com/news/home/20220526005502/en/


Contacts

Kasia Flood

marketing@tradingcentral.com


Merck to Present Latest Research From Oncology Portfolio at ASCO 2022

 • 30 abstracts highlighting key data encompassing the Company’s broad oncology clinical portfolio to be presented


DARMSTADT, Germany-Friday 27 May 2022 [ AETOS Wire ]


Not intended for US-, Canada- or UK-based media


(BUSINESS WIRE) -- Merck, a leading science and technology company, today announced the latest research representing the Company’s innovative oncology portfolio has been accepted for presentation at this year’s American Society of Clinical Oncology (ASCO) Annual Meeting, June 3-7, 2022. Data encompass Company-sponsored, investigator-sponsored, and external collaboration studies.


Abstracts to be shared at the meeting include data for the Company’s licensed medicines BAVENCIO® (avelumab), TEPMETKO® (tepotinib) and ERBITUX® (cetuximab), and its oncology pipeline. The presentations span key tumor types including advanced urothelial carcinoma (UC), advanced renal cell carcinoma (RCC), metastatic non-small cell lung cancer (NSCLC), metastatic colorectal cancer (CRC), and head and neck cancer (SCCHN).


“We look forward to coming together with the scientific community at ASCO 2022, where we will share the latest data from our portfolio, which demonstrate our determination to make a real difference in the lives of patients with some of the most challenging cancers,” said Victoria Zazulina, Head of Development Unit, Oncology, for the Healthcare business of Merck.


Select presentations include:


BAVENCIO® (avelumab): New analyses of long-term data from the Phase III JAVELIN Bladder 100 study of BAVENCIO as first-line maintenance treatment in advanced UC, including data from subgroups defined by best response to first-line chemotherapy and in patients who did or did not receive second-line treatment after BAVENCIO maintenance.


TEPMETKO® (tepotinib): Data for the oral MET inhibitor TEPMETKO include two poster presentations from the VISION trial reporting efficacy, safety and quality-of-life results of TEPMETKO in Asian patients with METex14 skipping NSCLC, and updated efficacy and safety results of TEPMETKO and exploratory biomarker analyses in patients with NSCLC with high-level MET amplification enrolled into Cohort B of the VISION trial based on liquid biopsy.


ERBITUX® (cetuximab): Abstracts from key investigator-sponsored studies (ISS) exploring ERBITUX-based combinations, including the Phase III FIRE-4 study of early switch-maintenance from ERBITUX/FOLFIRI to bevacizumab/5-FU and rechallenge in later lines for RAS wild-type mCRC patients, and the Phase II AVETUXIRI study evaluating BAVENCIO combined with ERBITUX and irinotecan for refractory microsatellite stable metastatic colorectal cancer.


Berzosertib: Results from research collaborations assessing the intravenous ataxia telangiectasia-mutated and Rad3-related protein kinase (ATR) inhibitor berzosertib, including the National Cancer Institute’s (NCI) Cancer Therapy Evaluation Program 9938 Phase I study of berzosertib plus irinotecan in patients with advanced solid tumors and NCI single-arm Phase II data of berzosertib plus topotecan in patients with relapsed extra-pulmonary small cell neuroendocrine carcinomas.


Below is a selection of key Merck-related abstracts accepted for presentation at ASCO 2022:


Title


Lead Author


Abstract/#


Session Title/Date/Time


BAVENCIO (avelumab)


 


 


 


Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (aUC): long-term outcomes from JAVELIN Bladder 100 in subgroups defined by response to 1L chemotherapy


BP Valderrama


4559


Genitourinary Cancer—Kidney and Bladder


Saturday, June 4, 2022


1:15 PM-4:15 PM CDT


Long-term outcomes in patients with advanced urothelial carcinoma (UC) who received avelumab first-line (1L) maintenance with or without second-line (2L) treatment: exploratory analyses from JAVELIN Bladder 100


J Bellmunt


4560


Genitourinary Cancer—Kidney and Bladder


Saturday, June 4, 2022


1:15 PM-4:15 PM CDT


TEPTMETKO (tepotinib)


 


 


 


Tepotinib in Asian patients with advanced NSCLC with MET exon 14 (METex14) skipping


T Kato


9120


Lung Cancer—Non-Small Cell Metastatic


Monday, June 6, 2022


8:00 AM-11:00 AM CDT


Clinical response to tepotinib according to circulating tumor (ct) DNA biomarkers in patients with advanced NSCLC with high-level MET amplification (METamp) detected by liquid biopsy (LBx)


X Le


9121


Lung Cancer—Non-Small Cell Metastatic


Monday, June 6, 2022


8:00 AM-11:00 AM CDT


ERBITUX (cetuximab)


 


 


 


Randomized study to investigate a switch maintenance concept with 5-FU plus Bevacizumab after FOLFIRI plus Cetuximab induction treatment versus continued treatment with FOLFIRI plus cetuximab: report of a secondary endpoint of the phase-III FIRE-4 study (AIO KRK-0114)


S Stintzing


3519


 


Gastrointestinal


Cancer—Colorectal and Anal


Saturday, June 4, 2022


8:00 AM - 11:00 AM CDT


Pipeline


 


 


 


Berzosertib (M6620)*


 


 


 


Targeting genomic instability in extrapulmonary small cell neuroendocrine cancers: a phase II study with ATR inhibitor berzosertib and topotecan


N Takahashi


8518


Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers


Monday, June 6, 2022


Live discussion: 12:26 PM CDT


NCI 9938: Phase I clinical trial of ATR inhibitor berzosertib (M6620, VX-970) in combination with irinotecan in patients with advanced solid tumors


LC Villaruz


3012


Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology


Sunday, June 5, 2022


Live Discussion: 4:42 PM CDT


*These studies are sponsored by the National Cancer Institute (NCI), part of the National Institutes of Health, under its Cooperative Research and Development Agreement with Merck for M6620.


All Merck press releases are distributed by e-mail at the same time they become available on the Merck website. Please go to www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.


Commitment to Cancer

Merck is a science-led organization dedicated to delivering transformative medicines with the goal of making a meaningful difference in the lives of people affected by cancer. Our oncology research efforts aim to leverage our synergistic portfolio in oncogenic pathways, immuno-oncology, and DNA Damage Response (DDR) to tackle challenging tumor types in gastrointestinal, genitourinary, and thoracic cancers. Our curiosity drives our pursuit of treatments for even the most complex cancers, as we work to illuminate a path to scientific breakthroughs that transform patient outcomes. Learn more at www.merckgrouponcology.com.


About BAVENCIO® (avelumab)

BAVENCIO is a human anti-programmed death ligand-1 (PD-L1) antibody. BAVENCIO has been shown in preclinical models to engage both the adaptive and innate immune functions. By blocking the interaction of PD-L1 with PD-1 receptors, BAVENCIO has been shown to release the suppression of the T cell-mediated antitumor immune response in preclinical models.7-9 In November 2014, Merck and Pfizer announced a strategic alliance to co-develop and co-commercialize BAVENCIO.


BAVENCIO Approved Indications

The European Commission (EC) has authorized the use of BAVENCIO as monotherapy for the first-line maintenance treatment of adult patients with locally advanced or metastatic urothelial carcinoma (UC) who are progression-free following platinum-based chemotherapy. BAVENCIO in combination with axitinib is indicated for the first-line treatment of adult patients with advanced renal cell carcinoma (RCC). BAVENCIO is also authorized by the EC for use as a monotherapy for the treatment of adult patients with metastatic Merkel cell carcinoma (MCC).


In the US, BAVENCIO is indicated for the maintenance treatment of patients with locally advanced or metastatic urothelial carcinoma (UC) that has not progressed with first-line platinum-containing chemotherapy. BAVENCIO is also indicated for the treatment of patients with locally advanced or metastatic UC who have disease progression during or following platinum-containing chemotherapy, or have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy.


BAVENCIO in combination with axitinib is indicated in the US for the first-line treatment of patients with advanced RCC. Additionally, the US Food and Drug Administration (FDA) granted accelerated approval for BAVENCIO for the treatment of adults and pediatric patients 12 years and older with metastatic MCC. This indication is approved under accelerated approval based on tumor response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.


BAVENCIO is currently approved for at least one indication for patients in more than 50 countries.


BAVENCIO Safety Profile from the EU Summary of Product Characteristics (SmPC)

The special warnings and precautions for use for BAVENCIO monotherapy include infusion-related reactions, as well as immune-related adverse reactions that include pneumonitis and hepatitis (including fatal cases), colitis, pancreatitis (including fatal cases), myocarditis (including fatal cases), endocrinopathies, nephritis and renal dysfunction, and other immune-related adverse reactions. The special warnings and precautions for use for BAVENCIO in combination with axitinib include hepatotoxicity.


The SmPC list of the most common adverse reactions with BAVENCIO monotherapy in patients with solid tumors includes fatigue, nausea, diarrhea, decreased appetite, constipation, infusion-related reactions, weight decreased and vomiting. The list of most common adverse reactions with BAVENCIO in combination with axitinib includes diarrhea, hypertension, fatigue, nausea, dysphonia, decreased appetite, hypothyroidism, cough, headache, dyspnea, and arthralgia.


About TEPMETKO® (tepotinib)

TEPMETKO is a once-daily oral MET inhibitor that inhibits the oncogenic MET receptor signaling caused by MET (gene) alterations. Discovered and developed in-house at Merck, TEPMETKO has a highly selective mechanism of action, with the potential to improve outcomes in aggressive tumors that have a poor prognosis and harbor these specific alterations.


TEPMETKO was the first oral MET inhibitor to receive a regulatory approval anywhere in the world for the treatment of advanced NSCLC harboring MET gene alterations, with its approval in Japan in March 2020. In February 2021, the U.S. Food and Drug Administration granted accelerated approval to TEPMETKO, making it the first and only once-daily oral MET inhibitor approved for patients in the U.S. with metastatic NSCLC with METex14 skipping alterations. Tepotinib is available in a number of countries, and under review by various other regulatory authorities globally. To meet an urgent clinical need, tepotinib is also available in a pilot zone of China in line with the government policy to drive early access for innovative medicines approved outside of China.


Merck is also investigating the potential role of tepotinib in treating patients with NSCLC and acquired resistance due to MET amplification in the Phase II INSIGHT 2 study of tepotinib in combination with osimertinib in MET amplified, advanced or metastatic NSCLC harboring activating EGFR mutations that has progressed following first-line treatment with osimertinib.


TEPMETKO Safety Profile from the EU Summary of Product Characteristics (SmPC)

The special warnings and precautions for use for TEPMETKO monotherapy include Interstitial lung disease (ILD) or ILD-like adverse reactions including pneumonitis, increase of Liver enzymes (ALT and AST), QTc prolongation, and embryo-foetal toxicity.


The most common adverse reactions in ≥ 20% of exposed to tepotinib at the recommended dose in the target indication are oedema, mainly peripheral oedema, nausea, hypoalbuminaemia, diarrhoea and increase in creatinine. The most common serious adverse reactions in ≥ 1% of patients are peripheral oedema, generalised oedema and ILD.


About Berzosertib (M6620)

Berzosertib is an investigational, intravenous, potent and selective inhibitor of the ataxia telangiectasia and Rad3-related (ATR) protein that blocks ATR activity in cells. Berzosertib is the first ATR inhibitor evaluated in a randomized clinical trial in any tumor type, and it is the lead candidate in Merck’s DNA Damage Response (DDR) inhibitor portfolio. It is currently being investigated in a number of internal and external studies with early phase I/II data in small cell lung cancer, ovarian cancer, and various solid tumors. Berzosertib, formerly known as VX-970, was licensed from Vertex Pharmaceuticals in 2017. Berzosertib is not approved for any use anywhere in the world.


About ERBITUX® (cetuximab)

ERBITUX is an IgG1 monoclonal antibody targeting the epidermal growth factor receptor (EGFR). As a monoclonal antibody, the mode of action of ERBITUX is distinct from standard non-selective chemotherapy treatments in that it specifically targets and binds to the EGFR. This binding inhibits the activation of the receptor and the subsequent signal-transduction pathway, which results in reducing both the invasion of normal tissues by tumor cells and the spread of tumors to new sites. It is also believed to inhibit the ability of tumor cells to repair the damage caused by chemotherapy and radiotherapy and to inhibit the formation of new blood vessels inside tumors, which appears to lead to an overall suppression of tumor growth. Based on in vitro evidence, ERBITUX also targets cytotoxic immune effector cells towards EGFR-expressing tumor cells (antibody-dependent cell-mediated cytotoxicity [ADCC]).


ERBITUX has already obtained market authorization in over 100 countries worldwide for the treatment of RAS wild-type metastatic colorectal cancer and for the treatment of squamous cell carcinoma of the head and neck. Merck licensed the right to market ERBITUX, a registered trademark of ImClone LLC, outside the U.S. and Canada from ImClone LLC, a wholly owned subsidiary of Eli Lilly and Company, in 1998.


About Merck

Merck, a leading science and technology company, operates across life science, healthcare and electronics. Around 61,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2021, Merck generated sales of € 19.7 billion in 66 countries.


Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as MilliporeSigma in life science, EMD Serono in healthcare, and EMD Electronics in electronics.


View source version on businesswire.com: https://www.businesswire.com/news/home/20220525005719/en/


Contacts

Noelle Piscitelli

Noelle.Piscitelli@emdserono.com

Phone: +1 781 427-4351



Lenovo Group: Full Year Financial Results 2021/22

  

Lenovo delivers another record year – crossing the US$70 billion revenue milestone and reaching US$2 billion in net income


(BUSINESS WIRE) -- Lenovo Group (HKSE: 992) (ADR: LNVGY) today announced record fiscal year results for the Group, with historic highs for both profit and revenue. Annual net income reached the US$2 billion mark, up 72% year on year, with revenue growing by US$10 billion for the second year running to over US$71 billion. All main business groups were profitable for the full fiscal year - with strong growth momentum in mobile, infrastructure, and solutions and services businesses.


Lenovo successfully overcame macro-environmental challenges and demonstrated both agility and resilience as it navigated industry-wide supply shortages, pandemic disruption, geopolitical uncertainties, and higher inflation to deliver a record year.


The digital and intelligent transformation trend continues to accelerate, presenting the Group with strong growth opportunities. More than 50% of companies now have digitalization as part of their corporate strategy, up from just over one third two years ago. The hybrid work model is a long-term change that will continue to drive strong demand not only for smart devices and data center infrastructure, but also for scenario-driven solutions such as smart collaboration, smart home, and smart office.


Lenovo continued to strengthen its competitiveness to drive sustainable profitable growth. It has already made strong progress toward doubling R&D investments within three years from fiscal year 2021/2022, up 43% year on year to US$2 billion. And will continue to realize its ESG goals and commitments. The company is confident that by leveraging its clear strategy, competing with its unique competitive advantage of global-local model, and the right balance between innovation and efficiency, it can overcome any challenges to capture opportunities.


Lenovo’s Board of Directors declared a final dividend of 3.8 US cents or 30.0 HK cents per share for the fiscal year ended March 31, 2022.


Financial Highlights:


 


FY 21/22


US$ millions


FY 20/21


US$ millions


Change


 


 


Q4 21/22


US$ millions


Q4 20/21


US$ millions


Change


 


Group Revenue


71,618


60,742


18%


16,694


15,630


7%


Pre-tax income


2,768


1,774


56%


520


380


37%


Net Income (profit attributable to equity holders)


2,030


1,178


72%


412


260


58%


 


 


Basic earnings per share (US cents)


17.45


9.54


7.91


3.52


2.19


1.33


Chairman and CEO quote – Yuanqing Yang:


“Although last year was challenging for the world, with the accelerated global digital and intelligent transformation, Lenovo delivered a record year of profit and revenue,” said Yuanqing Yang, Lenovo Chairman and CEO. “All our main businesses are now profitable for the full year, and our new growth engines – SSG, ISG and Mobile – are showing strong momentum. We will capture this window of opportunity, double our R&D investment, drive service-led transformation, realize our ESG goals, and stay flexible and resilient to bring the entire company to new heights.”


Solutions and Services Group (SSG): delivering strong growth and high margins - driving higher overall profitability for the Group


Opportunity:


The trillion-dollar IT services market continues to expand. With the hybrid work model, the demand for digital workplace services is expected to reach US$93 billion by 2025. Equally, research is showing that more than 90% of CIOs are willing to consider adopting as-a-service offerings.


FY21/22 performance:


In the last year SSG delivered high profitability and high growth, with revenue reaching an all-time high of US$5.4 billion, up almost 30% year on year. Operating margin was 22%.


There was strong double-digit growth across all segments, in particular for managed services where revenue grew more than 60% year on year, with strong growth from the TruScale as-a-service business. Project and solution services saw revenue grow 28% year on year, as vertical solutions more than doubled on the previous year.


Revenue from managed services and project and solution services now accounts for almost half of SSG’s business.


Sustainable Growth:


SSG continued to invest in software tools, platforms, and repeatable vertical solutions with Lenovo’s own IP, focusing in particular on driving deeper in vertical solution capabilities in the key industries of manufacturing, retail, healthcare, education, and smart cities.


TruScale as-a-service continued to expand to include broader digital workplace solutions, and the company developed hybrid cloud solutions.


Further exploration of Metaverse solutions continues to be a focus.


Infrastructure Solutions Group (ISG): profitable with record revenue


Opportunity:


ISG continued to benefit from the ICT infrastructure upgrade where the data center market alone is expected to reach US$183 billion by 2025, Edge infrastructure is anticipated to exceed US$41 billion, and the hybrid cloud market will exceed US$120 billion. With data creation expected to double by 2025, the opportunities for data processing and storage will continue to grow.


FY21/22 performance:


ISG hit an important milestone, becoming profitable over the full year, with record revenue of US$7 billion, up more than 13% year-on-year.


All parts of the high-value businesses such as storage, software, services, and HPC set individual revenue records.


Sustainable Growth:


ISG continued to grow premium to the market by enhancing its full stack capabilities that cover both Cloud Service Provider (CSP), and Enterprise/Small and Medium Business (SMB) segments.


Investments in in-house design and manufacturing capabilities will continue, while expanding into fast-growing areas such as edge and cloud services.


ISG further differentiated with green technology such as its Neptune Liquid Cooling system.


Intelligent Devices Group (IDG): record revenue, profitability growth


Opportunity:


The market for smart devices continues to benefit from the new normal of hybrid work. While consumer PC demand may slow in the short term, commercial demand remains strong. IoT endpoint shipments are expected to reach US$2.3 billion in 2025, and the smart collaboration market is expected to surpass US$80 billion by 2025.


FY21/22 performance:


Revenue exceeded US$60 billion for the first time, up 18% year-on-year, and profitability improved by almost US$1 billion year-on-year.


PCs maintained the #1 position as all premium segments delivered year-on-year revenue growth of more than 30%.


Smartphone revenue outgrew the market by 30-points, while doubling operating profit to more than US$360 million, a record since the acquisition of Motorola Mobility.


Expansion beyond PCs continues and now more than 18% of IDG revenue comes from other smart devices, embedded computing/IoT, and scenario-based solutions.


Sustainable Growth:


Lenovo continues its strategy of investing in innovation, particularly in premium segments, to extend its leading position in PCs while maintaining industry-leading profitability.


Further expansion in smartphones, tablets, embedded computing/IoT, and scenario-based solutions such as Smart Collaboration, Smart Home and Smart Office, continues to provide new growth engines.


Q4 Performance


In Q4, despite the disruption to supply and production due to COVID-19 outbreaks in China, Lenovo still closed the final quarter of the year with strong results. Fourth-quarter net Income achieved a year-on-year improvement of more than 50% and revenue grew almost 7% year on year to US$16.7 billion, with all three business groups contributing to the company’s profitable growth. SSG revenue grew 28% and improved its operating margin by more than 1 point year on year. ISG sustained its profitability for the second quarter. IDG improved its operating margin year on year for the 18th consecutive quarter.


Operational highlights and investing for the future


R&D investment - Lenovo recently set out its bold vision for the year ahead that includes hiring 12,000 R&D professionals around the world over the next three years as part of its commitment to double Research and Development investment. Last year, R&D investment grew 43% year on year to reach a historic high exceeding US$2 billion. R&D headcount grew 48% year on year, surpassing 15,000 with one in every five employees now working in R&D. Investments are focused on the New IT architecture, or client-edge-cloud-network-intelligence, and are balanced to optimize between short, medium, and long-term payback.


ESG commitments – After exceeding its 2020 emissions reduction goals a year ahead of schedule, Lenovo has committed to a vision to achieve net-Zero by 2050 and is working with the Science Based Target Initiative to establish goals that support this vision. Lenovo has reported on sustainability topics since 2008, including outlining its work and goals around climate change mitigation, the circular economy, and sustainable materials. In addition to the net-zero vision, Lenovo has committed to positively impacting 15 million lives through philanthropic programs and partnerships by 2025. The company’s philanthropic arm, the Lenovo Foundation, provides smarter technology for all by empowering underrepresented communities with access to technology and STEM education.


About Lenovo


Lenovo (HKSE: 992) (ADR: LNVGY) is a US$70 billion revenue global technology powerhouse, ranked #159 in the Fortune Global 500, employing 75,000 people around the world, and serving millions of customers every day in 180 markets. Focused on a bold vision to deliver smarter technology for all, Lenovo has built on its success as the world’s leading PC player by expanding into new growth areas of infrastructure, mobile, solutions and services. This transformation together with Lenovo’s world-changing innovation is building a more inclusive, trustworthy, and sustainable digital society for everyone, everywhere. To find out more visit https://www.lenovo.com,and read about the latest news via our StoryHub.


       

 


 

 


 


 


LENOVO GROUP


FINANCIAL SUMMARY


For the fiscal quarter and full year ended March 31, 2022


(in US$ millions, except per share data)


       

 


 

 


 


 


 


 


Q4

FY21/22


Q4

FY20/21


 


Y/Y CHG


 


 


FY21/22


 


FY20/21


 


Y/Y CHG


Revenue


 


16,694


15,630


7%


 


71,618


60,742


18%


Gross profit


 


2,864 


2,688 


7%


 


12,049


9,768


23%


Gross profit margin 


 


17.2% 


17.2% 


0 pts


 


16.8%


16.1%


0.7 pts


Operating expenses


 


(2,275) 


(2,209)


3%


 


(8,968)


(7,588)


18%


R&D expenses


 


(576)


(417)


38%


 


(2,073)


(1,454)


43%


(included in operating expenses)


 

 


 


 


 

 


 


 


 


 

 


 


 


 

 


 


 


Expenses-to-revenue ratio


 


13.6% 


14.1% 


(0.5) pts


 


12.5%


12.5%


0 pts


Operating profit


 


589 


479 


23%


 


3,081


2,180


41%


Other non-operating income/(expenses) – net


 


(69)  


(99) 


(30%)


 


(313)


(406)


(23%)


Pre-tax income


 


520 


380 


37%


 


2,768


1,774


56%


Taxation


 


(99) 


(95) 


4%


 


(623)


(461)


35%


Profit for the period/year


 


421 


285 


48%


 


2,145


1,313


63%


Non-controlling interests


 


(9) 


(25) 


(63%)


 


(115)


(135)


(14%)


Profit attributable to equity holders


 


412


260


58%


 


2,030


1,178


72%


Earnings per share (US cents)


 


 


 


 


 


 


 


 


Basic


 

3.52


2.19


1.33


 

17.45


9.54


7.91


Diluted


 

3.20


1.94


1.26


 

15.77


8.91


6.86


View source version on businesswire.com: https://www.businesswire.com/news/home/20220525006071/en/


Contacts

Press Contacts

Hong Kong – Angela Lee, angelalee@lenovo.com, +852 2516 4810

London – Charlotte West, cwest@lenovo.com, +44 7825 605720

Zeno Group - LenovoWWcorp@zenogroup.com

Thursday, May 26, 2022

SCREEN Increases Efforts to Reduce the Environmental Impact of the Semiconductor Industry

 New Efforts Are Expected to Accelerate Eco-friendly Development Leading to the Realization of a Sustainable Society


KYOTO, Japan-Thursday 26 May 2022 [ AETOS Wire ]


(BUSINESS WIRE) -- SCREEN Semiconductor Solutions Co., Ltd. (SCREEN SPE), a subsidiary of SCREEN Holdings Co., Ltd., has announced it will increase its efforts to reduce the company’s environmental overall impact.


The SCREEN Group is committed to both achieving a sustainable global society and to improving its sustainable value (social value) and has formulated a medium-term management plan titled Sustainable Value 2023 targeting these goals. The plan identifies specific issues in each of the environmental, social, and governance (ESG) fields.


Concerning the environment, SCREEN is working to provide products and services that actively contribute to the reduction of ecological burden. Its efforts include improving the environmental performance of its products, reducing the effects of its business activities on climate change, promoting effective utilization of water resources, increasing recycling of products and parts, and helping to preserve biodiversity.


Concretely, SCREEN SPE seeks to reduce the impact that semiconductor manufacturing processes have on the environment and contribute to the realization of a sustainable global society. As a leading company in the area of cleaning equipment, it is also committed to supporting the growth of the entire semiconductor industry over the long term.


Demand for semiconductor devices has increased on a global scale in recent years, mainly due to the widespread adoption of 5G-compatible smartphones and the growing requirements of data centers accompanying the digital transformation (DX) now occurring worldwide. The growing demand for in-vehicle systems required for electric vehicles and self-driving cars and the rapid spread of IoT infrastructure, especially for industrial equipment, are also driving this change.


However, as reliance on semiconductor devices has grown, the environmental impact created by their manufacturing processes has become a shared concern for the entire semiconductor industry. Issues that must be addressed include high energy consumption and the use of chemical substances, scarce materials, and ultrapure water, and the emission of greenhouse gases.


With this trend in mind, SCREEN SPE has agreed to join the Sustainable Semiconductor Technologies and Systems (SSTS)* research program led by imec, a world-leading research and innovation hub based in Leuven, Belgium. The SSTS program is designed to help the semiconductor industry reduce its overall environmental impact.

Led by Director Lars-Ake Ragnarsson, the new program leverages imec’s expertise in the areas of infrastructure, technology, and equipment. This includes using concrete, highly reliable models plus detailed carbon footprint analyses to predict the effects of manufacturing processes on the environment. The initiative is ultimately intended to support the entire semiconductor value chain in decreasing its ecological footprint.


By joining the SSTS program, SCREEN SPE hopes to accelerate its development of environmentally friendly manufacturing equipment, particularly semiconductor cleaning and coater/developer systems. It expects the decision to enable it to provide the industry with products offering even greater environmental performance.


imec Press release

Imec unites partners from the semiconductor value chain to jointly target net-zero emissions for chip manufacturing


*SSTS (Sustainable Semiconductor Technologies and Systems)


View source version on businesswire.com: https://www.businesswire.com/news/home/20220523005556/en/


Contacts

SCREEN Holdings Co., Ltd.

Public Relations Division, PR & IR Department

Maki Yamamoto, Atsushi Kurosaki,

+81-75-414-7131

nr-info@screen.co.jp


NEC and Juniper Networks Deploy Algeria Telecom’s Nationwide 5G-Ready IP Metro Network


 Network automation tools deployed to drive assured user experience

TOKYO & SUNNYVALE, Calif-Thursday 26 May 2022 [ AETOS Wire ]


(BUSINESS WIRE) -- NEC Corporation (NEC; TSE: 6701), a leading global IT and network transformation services provider, and Juniper Networks (NYSE: JNPR), a leader in secure, AI-driven networks, today announced they have worked with Algeria Telecom, the leader in the Algerian telecommunications market, to roll out its modernized, nationwide IP metro commercial network to support current demand for increased capacity as well as future needs driven by 5G and FTTx.


This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220524005904/en/


Algeria Telecom has formed a mid-term strategic plan to implement a transport network with a homogenized, optimized topology as well as automation capabilities that guarantee bandwidth and future-proofing of its infrastructure in a growing market. NEC and Juniper have successfully delivered Algeria Telecom’s next generation IP metro network while ensuring quality of service, driving toward the best possible user experience, at scale.


As the innovative foundation of the new platform, Algeria Telecom has selected high-performing, secure solutions from the Juniper Networks portfolio for SDN-ready, cloud-grade networking and feature-rich, simple and secure connectivity at scale, deployed as access nodes to create separate pre-aggregation, aggregation and access domains for optimal reliability. Elements of the Juniper Paragon Automation cloud-native solution suite, Paragon Pathfinder and Paragon Planner have been deployed, enabling Algeria Telecom to achieve deep visibility and simplified operations of its network and services. This paves the way for assured user experiences within complex 5G and multicloud services. All of the Juniper platforms run on a single operating system, Junos® OS, to create an easily-managed, simplified and open solution.


NEC leveraged its extensive transport network integration and engineering capabilities to skillfully deliver best-in-class solutions that are dynamically tailored for Algeria Telecom’s requirements. Moreover, NEC orchestrated the total project as a ‘One-Stop Network Integrator’, capitalizing on its professional services based on global and local experiences ranging from network analysis and consulting, to design, implementation, migration and operation of high-capacity networks.


In addition, NEC and Juniper’s solid partnership, built on a track record of delivering innovative networking to hundreds of customers across the globe, has enabled the tight coordination between the parties to achieve Algeria Telecom’s objective of providing a high-capacity innovative network to accommodate surging data traffic and a future of diversified 5G use cases.


"The successful completion of the IP metro network modernization project by our partners, NEC Corporation and Juniper Networks, will allow us to make the migration to IPV6 and the initiation of digital transformation, as well as the implementation of high speed internet, as we best satisfy the needs of Algeria Telecom customers," said Mr. Adel Bentoumi, CEO of Algeria Telecom.


“The rapid growth of network traffic is a clear indication of the need for modernization and expansion of network capacity,” said Allahoum Hocine, Head of IP Core, Algeria Telecom. “NEC and Juniper have been extremely attentive to our needs, both technical and commercial, working as an extension of our team with their outstanding local engineering abilities, as well as their relentless efforts to assure quality of experience and on-time delivery. Overall, the innovative solutions from Juniper to enable this automated metro cloud architecture have helped us achieve our strategic goals and thrive as we pave the way for 5G.”


“Networks have always been a key asset for service providers, but going forward they will be the foundation for every aspect of business transformation in the 5G and cloud era. Algeria Telecom is jumping ahead of the curve by investing in an open, agile and automated network architecture that can drive simplified operations, improved economics and superior end-user experiences,” said Brendan Gibbs, Senior Vice President, Automated WAN Solutions, Juniper Networks.


“Our customer-first approach and uncompromising quality are values that are deeply ingrained in our culture,” said Hideyuki Ogata, General Manager, Service Provider Solutions Department, NEC Corporation. “This, combined with our accumulated domain expertise at NEC 5G Transport Network Center of Excellence (CoE) in EMEA, makes us confident that our extended engagement through this partnership will help enable continuous success and advancement of Algeria Telecom’s business.”


Additional Resources:

The NEC-Juniper Global Alliance


About Algeria Telecom


Algeria Telecommunications Corporation (French: Algérie Télécom) is the state owned telecom operator in Algeria. It is a public company active in the fields of fixed phone and internet. Algérie Télécom was created on 5 August 2000.


For more information, visit Algeria Telecom at www.algerietelecom.dz


About Juniper Networks


Juniper Networks is dedicated to dramatically simplifying network operations and driving superior experiences for end users. Our solutions deliver industry-leading insight, automation, security and AI to drive real business results. We believe that powering connections will bring us closer together while empowering us all to solve the world’s greatest challenges of well-being, sustainability and equality. Additional information can be found at Juniper Networks (www.juniper.net) or connect with Juniper on Twitter, LinkedIn and Facebook.


Juniper Networks, the Juniper Networks logo, Juniper, Junos, and other trademarks listed here are registered trademarks of Juniper Networks, Inc. and/or its affiliates in the United States and other countries. Other names may be trademarks of their respective owners.


About NEC Corporation


NEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of “Orchestrating a brighter world.” NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at http://www.nec.com.


LinkedIn: https://www.linkedin.com/company/nec/

YouTube: https://www.youtube.com/user/NECglobalOfficial

Facebook: https://www.facebook.com/nec.global/

Twitter: https://twitter.com/NEC_corp


NEC is a registered trademark of NEC Corporation. All Rights Reserved. Other product or service marks mentioned herein are the trademarks of their respective owners. ©2022 NEC Corporation.


View source version on businesswire.com: https://www.businesswire.com/news/home/20220524005904/en/


Contacts

Penny Still

Juniper Networks

pstill@juniper.net

+44 (0) 1372 385 692


Joseph Jasper

NEC Corporation

j-jasper@nec.com


A green, resilient, inclusive approach to development can usher in a new model of growth for MENA: Badr Jafar at the World Economic Forum

 - The UAE has invested over $40 billion in clean energy over the last 15 years, with plans to invest $160bn in clean and renewable energy sources over the next 30 years.


- 85% of 300 high-net-worth investors in the Middle East intend to increase their exposure to ESG and sustainable investments in the next 5 years.

       


Sharjah, United Arab Emirates-Thursday 26 May 2022 [ AETOS Wire ]


The World Economic Forum (WEF) hosted an expert dialogue on the collaborative action Middle East leaders must take to navigate between net-zero ambitions and socioeconomic realities. The session, titled “Transitioning to a Green Middle East,” took place during the WEF Annual Meeting 2022 in Davos, Switzerland. The dialogue came at a critical time, with the next two United Nations Climate Change Conferences, COP27 and COP28, both set to be hosted in the region, by Egypt and the United Arab Emirates, respectively.


Moderated by The National Editor-In-Chief, Mina Oraibi, the session convened leaders in government and business to share their insights on the path to a more resilient and sustainable future. Participants included Minister of Economy of the United Arab Emirates, Abdulla Bin Touq Al Marri, Minister of Economy and Planning of Saudi Arabia, Faisal Alibrahim, Chief Executive Officer of Crescent Enterprises, Badr Jafar, Chief Executive Officer of Qatar Financial Centre, Yousuf Mohamed Al-Jaida, and Associate Professor of Molecular Biology at Sultan Qaboos University, Lamya Al Haj.


The Middle East and North Africa (MENA) is one of the most climate-vulnerable regions, with the destructive impact of climate change becoming increasingly evident in the shape of droughts, water scarcity, and elevated pollution levels.


Despite this, the region is regarded as well-positioned to become a leader in renewable energy and in green and blue hydrogen. And while oil and gas will continue to play a significant role in the regional energy landscape, the region has witnessed the promising emergence of a new, more circular economy. Regional leaders are at a crucial crossroads as they foster more sustainable economies, while addressing the implications of the energy transition.


“For years, I’ve been advocating sensible energy policy that supports a greener evolution of energy systems whilst ensuring we do not put energy security at risk or impede the economic and social progress of developing regions around the world,” Badr Jafar, Chief Executive Officer of Crescent Enterprises, remarked. “A green, resilient, inclusive approach to development can usher in a new model of growth for MENA, creating jobs while delivering the benefits of climate resilience, decarbonization, cleaner air and water, healthier oceans, and sustainable food and agricultural systems.” he added.


Crescent Enterprises, a UAE-based global conglomerate, continues to invest in the energy evolution through its own operations, portfolio companies, and corporate citizenship initiatives. In the past 3 years, the company has invested over $300MM across the world in sustainable investments, over 70% of which has gone into global growth markets. It has also been particularly active in the transition to sustainable transport in the region through its shipping and logistics subsidiaries, Gulftainer and Momentum Logistics, and by co-launching a UAE-based sustainable transport company, ION, aimed at creating a zero-emissions transport infrastructure in the region.


Session participants underscored a shared sentiment that mobilizing climate action in the region will require a localised, multi-stakeholder approach. Optimistically, government, business, and civil society-led initiatives are on the rise in the region, with a notable growth in the capital, time, and talent invested in the infrastructure needed to progress. The UAE has invested $40bn in clean energy over the past fifteen years, with plans to invest an additional $160bn in renewable energy over the next three decades on the road to net zero.


“Energy security is a high priority. And it’s something we need to really understand. The fragmentation that’s happening globally, and energy supplies, will really affect the aspects of energy going forward. With that, the UAE has a long-term plan.” remarked Minister of Economy of the United Arab Emirates, Abdulla Bin Touq Al Marri. “The creation of the company Masdar, the implementation of solar panels, global projects helping the world to diverse their energy supply, all show the UAE’s investment in future energy security […] The investment in diversifying energy aspects is important and vital for any future development of the region.”


Badr Jafar cited the UAE’s landmark Net Zero Pledge and related strategy of going net-zero by 2050 as a great example of the practical and conducive policy, adding “This is all achievable with smart energy policy, as opposed to politicised rhetoric. The UAE’s Net Zero Pledge and related strategy of going net-zero by 2050 is a great example of a practical and conducive policy that relies on a mix of renewables, natural gas, hydrogen, and nuclear in order to ensure affordable, accessible and acceptable energy is available to meet the growing demands of industry and our population”


Nearly 2,500 leaders across government, business, civil society, academia, and media from across the globe have participated in the World Economic Forum's Annual Meeting 2022 this week. With all discussions centred around the theme, “History at a Turning Point: Government Policies and Business Strategies.” A recording of the “Transitioning to a Green Middle East” session can be viewed here.


ENDS


Notes to editors


 


About Crescent Enterprises


Crescent Enterprises is a multinational company headquartered in the United Arab Emirates. It operates under four platforms: CE-Operates, CE-Invests, CE-Ventures, and CE-Creates, which span diverse sectors including ports and logistics, power and engineering, food & beverage, business aviation, and across verticals such as private equity, venture capital, and business incubation.


www.crescententerprises.com 


Contacts

Mohammed Al Barazenjey 


00971557163727


mb@saharapr.com


Technology Innovation Institute Launches Pioneering Research Facility in Abu Dhabi for Key Industries in the Region

  New Hub at Tawazun Industrial Park Houses Seven Workshops, Five Specialized Laboratories, Focusing on HPEM, HEL and Acoustics



Abu Dhabi, United Arab Emirates-Tuesday 24 May 2022 [ AETOS Wire ]

Technology Innovation Institute (TII), the applied research pillar of Abu Dhabi’s Advanced Technology Research Council (ATRC) today announced that its Directed Energy Research Center (DERC), has launched a state-of-the-art facility in Tawazun Industrial Park (TIP), a regional hub for strategic businesses in the safety and security sector that offering world-class business infrastructure.

The facility comprises seven distinct workshops and five specialized laboratories. Each caters to a specific research domain from mechanical and electronics workshops, prototype test area, coil winding, armature filling, dielectric testing, and acoustic prototyping lab. The laboratories are Pulse Power Lab, Semi-Anechoic Chamber, Tempest Chamber, Acoustic Lab, and Laser Development Lab.

The facility hosts three mobile research laboratories that can be used in conjunction with the primary laboratories or be deployed in the field for outdoor testing, including two Electromagnetic Mobile Labs and a Mobile Laser Lab. Applications DERC focuses on include High-Power ElectroMagnetics (HPEM) and Electromagnetic Compatibility (EMC) testing. DERC also undertakes innovative research in the HPEM and Pulsed Power domain, along with prequalification tests for multiple industries in the region.

A first for the GCC, DERC’s facility conducts industry-leading Radio Frequency testing to manufacture and characterize high power, solid-state devices. The facility also carries out highly sensitive Acoustic experiments that require a high degree of isolation from environmental sound and vibrations, supporting development and characterization of unusual acoustic transmitters and sensors.

The controlled environment in the labs identifies involuntary sound sources in complex electronic systems that might lead to side-channel leakage. DERC’s custom-developed optical vibration analysis tools can examine mechanical system behavior across a wide range of frequencies.

Additionally, the Center has also introduced groundbreaking Signal Electronics & Acoustics (SEA) prototyping to facilitate the local development of advanced solutions like small/high-density RF and acoustic devices. The facility can undertake soldering, complex mechanical assembly, testing while advancing prototyping in 3D printing.

DERC’s Mobile Laser lab is the first of its kind in the region to conduct laser experiments outdoors to explore propagation of a high-power laser and study the effect on targets at a distance in the arid Gulf environment. Emitting a multi-kW continuous laser, the lab is equipped with a telescope mounted on a pan-tilt, focusing a beam over a distance ranging from 200 m to 2,000 m. Connected to an electrical generator, the mobile lab is designed to be used autonomously outdoors under extreme temperatures of up to 50°C.

Speaking on the new facility, Dr. Ray O. Johnson, CEO of Technology Innovation Institute (TII) and Acting CEO, ASPIRE, said: “At TII, we are committed to attracting global talent to our research centers. Given this priority, we are proud to witness DERC’s phenomenal achievement with this facility. Such innovative hubs draw a growing number of researchers as well as customers keen to benefit from testing capabilities across varied sectors.”

Dr. Chaouki Kasmi, Chief Researcher, Directed Energy Research Center (DERC), said: “We are excited to finally witness the launch and cutting-edge capabilities of this new facility that will offer us a distinct advantage while giving the UAE much-needed autonomy when it comes to ensuring comprehensive testing and establishing a reliable supply chain.”

The Center’s achievement of bringing together multiple core capabilities under one roof provides opportunities to take HPEM testing to greater heights while enabling the testing of high-power lasers in compact environments.

Contacts

Technology Innovation Institute

Sneha Sivanand

Comms@atrc.ae


Permalink : https://www.aetoswire.com/news/technology-innovation-institute-launches-pioneering-research-facility-in-abu-dhabi-for-key-industries-in-the-region/en

Lumenis OptiLight Wins 2022 MedTech Breakthrough Award: Best New Technology Solution for Ophthalmology

 For the third straight year, Lumenis wins award recognizing outstanding medical companies and technologies


YOKNE’AM ILLIT, Israel-Thursday 26 May 2022 [ AETOS Wire ]


(BUSINESS WIRE)-- Lumenis Be., a leading energy-based medical device company for aesthetic and eye care applications, today announced that OptiLight has received the highly competitive MedTech Breakthrough Award for “Best New Technology Solution for Ophthalmology.” This year, MedTech’s range of health and medical technology categories attracted more than 3,900 nominations from over 15 countries, from which MedTech selected OptiLight for this prestigious recognition. The win follows Lumenis’ MedTech awards for Best Overall Medical Device Company in 2021 and Best New Surgical Technology Solution in 2020.


OptiLight is a groundbreaking, light-based treatment. It is the first and only light treatment FDA approved for management of dry eye disease, a very common condition that causes dry, gritty eyes and fluctuating vision for an estimated 49 million Americans.1 Lumenis’ patented, innovative Optimal Pulse Technology (OPT™) offers targeted, uniform, precise, and controlled treatment that safely and effectively breaks the vicious cycle of inflammation associated with dry eye disease.


“Dry eye disease is highly prevalent and difficult to manage, and traditional treatments like warm compresses and artificial tears treat the symptoms but not the underlying pathology,” said James Johnson, managing director, MedTech Breakthrough. “OptiLight is leading a revolution in managing dry eye disease with ‘breakthrough’ technology that allows doctors to treat patients quickly, in-office. With broad potential for tens of millions with dry eye disease, OptiLight stands out from the crowd to become our 2022 Best New Technology Solution for Ophthalmology.”


Lumenis introduced OptiLight in May 2021 and recently launched a national media campaign featuring singer-songwriter and actress Mandy Moore (This Is Us) to increase awareness for dry eye disease and encourage people who might be suffering from this condition to seek out a physician who offers OptiLight (www.TreatMyDryEye.com).


“We’re grateful to MedTech for honoring OptiLight for its innovation and impact in eye care,” said Lumenis CEO Tzipi Ozer-Armon. “Lumenis is committed to raising the bar for patients’ health by providing cutting-edge solutions and treatment innovations. As the only light-based treatment for dry eye disease, OptiLight has the power to elevate dry eye management and improve health and quality of life for millions of people around the world.”


1. Dana R et al. Patient-Reported Burden of Dry Eye Disease in the United States: Results of an Online Cross-Sectional Survey. Am J Ophthalmol. 2020 Aug; 216:7-17.


About Lumenis


www.lumenis.com


Lumenis is a leading energy-based medical device company for aesthetic and ophthalmic applications in the area of minimally invasive clinical solutions. It is regarded as a world-renowned expert in developing and commercializing innovative energy-based technologies, including Laser, Intense Pulsed Light (IPL) and Radio-Frequency (RF). For nearly 50 years, Lumenis’ groundbreaking products have redefined medical treatments and have set numerous technological and clinical gold standards. Lumenis has successfully created solutions for previously untreatable conditions, as well as designed advanced technologies that have revolutionized existing treatment methods.


About MedTech Breakthrough


Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is devoted to honoring excellence in medical and health related technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough health and medical companies and products in categories that include Patient Engagement, mHealth, Health & Fitness, Clinical Administration, Healthcare IoT, Medical Data, Healthcare Cybersecurity and more. For more information visit MedTechBreakthrough.com.


PB-00044810 Rev A


View source version on businesswire.com: https://www.businesswire.com/news/home/20220525005607/en/


Contacts

Colleen Ketchum

colleen.ketchum@precisionvh.com



Permalink : https://www.aetoswire.com/news/lumenis-optilight-wins-2022-medtech-breakthrough-awardnbspbest-new-technology-solution-for-ophthalmology/en


E-LAND Innople Chooses Rimini Street Support Services for SAP S/4 HANA

 South Korean Conglomerate Significantly Reduces Annual Maintenance Costs and Reinvests Savings in New Innovation Projects




LAS VEGAS-Thursday 26 May 2022 [ AETOS Wire ]


(BUSINESS WIRE) -- Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, the leading third-party support provider for Oracle and SAP software products, and a Salesforce partner, today announced that E-LAND Innople, an IT affiliate of the South Korean conglomerate E-Land Group, has chosen Rimini Street Support for SAP. The move has drastically cut E-LAND Innople’s annual maintenance costs and freed up budget to fuel new IT technology, digital transformation, and online expansion.


Rimini Street Support Increases Business Agility


E-LAND Innople provides IT solutions across various industries including fashion, distribution, hotels, restaurants, and construction. The company is responsible for the IT operations of E-Land Group, including ERP management, AI and big data, leading a number of successful digital transformation efforts with forward-thinking investments. It also has adopted an agile innovation strategy to respond rapidly to the market environment and the rise of new technologies.


The team at E-LAND Innople was attracted to Rimini Street’s security capabilities, reliability, and its premier support services and global team, which is known in the industry for its high levels of client satisfaction. Rimini Street supports E-LAND Innople based on its unique and specific business situation, which included the need to reduce costs due to external factors such as the global pandemic, along with improving service quality. The company was particularly interested in Rimini Street's ability to provide support services regardless of whether vendors end their own full support for existing product versions.


At the outset, Rimini Street engineers comprehensively analyzed E-LAND Innople's business and digital infrastructure, including areas that required cost reductions. As a result, Rimini Street has served as a true consulting partner for IT operations rather than simply providing third-party support for the sake of cost savings.


“E-LAND Innople sought ways to reduce ERP maintenance costs after an internal review that revealed an SAP maintenance switch could contribute to a drastic reduction in operating costs," said Kim Ji-won, CEO of E-LAND Innople. "And the savings are only part of the story. Rimini Street’s dedicated SAP engineers provide incredibly rapid response and resolution, which enables us to make business decisions faster and more effectively.”


Through this partnership, E-LAND Innople not only receives extraordinary support service from Rimini Street, with IT incidents handled quickly and professionally, the company is significantly reducing the cost to maintain its ERP system. With these savings, E-LAND Innople can focus innovating its existing service to other E-Land Group subsidiaries and investing and enhancing its own customer bolt-on (CBO) program, which is specialized for E-Land Group's distribution, fashion, and logistics businesses and integrates with various other solutions including SAP ERP.


A Higher Level of Support to Meet Business Needs


E-LAND Innople works directly with dedicated, expert engineers who guarantee prompt, professional service and faster resolution for support and maintenance requirements. Like all Rimini Street clients, E-LAND Innople benefits from the Company’s flexible, premium-level enterprise software support model, including its industry-leading Service Level Agreement of 10-minute response times for all critical Priority 1 cases, with local engineers available 24/7/365 for all issues. All clients are also assigned a dedicated Primary Support Engineer with an average of 20 years of experience working with enterprise software and backed by a team of functional and technical engineers.


“Most leading companies in Korea, including E-LAND Innople, are focused on pursuing innovation in a fiercely competitive environment,” said Hyungwook Kevin Kim, regional general manager, Korea, Rimini Street. “Rimini Street helps customers achieve a competitive advantage and drive growth by dramatically reducing application maintenance costs, which make up a significant portion of IT operating costs, ultimately allowing customers to use the savings to fund new business innovations.”


Rimini Street continues to expand its portfolio of solutions that are enabling organizations like E-LAND Innople to chart a Smart Path forward by helping them optimize, evolve and transform their technology landscape and systems as they build and execute their business of tomorrow.


About Rimini Street, Inc.


Rimini Street, Inc. (Nasdaq: RMNI) is a global provider of enterprise software products and services, the leading third-party support provider for Oracle and SAP software products and a Salesforce partner. The Company offers premium, ultra-responsive and integrated application management and support services that enable enterprise software licensees to save significant costs, free up resources for innovation and achieve better business outcomes. To date, nearly 4,700 Fortune 500, Fortune Global 100, midmarket, public sector and other organizations from a broad range of industries have relied on Rimini Street as their trusted application enterprise software products and services provider. To learn more, please visit http://www.riministreet.com, follow @riministreet on Twitter and find Rimini Street on Facebook and LinkedIn. (IR-RMNI)


Forward-Looking Statements


Certain statements included in this communication are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “may,” “should,” “would,” “plan,” “intend,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “seem,” “seek,” “continue,” “future,” “will,” “expect,” “outlook” or other similar words, phrases or expressions. These forward-looking statements include, but are not limited to, statements regarding our expectations of future events, future opportunities, global expansion and other growth initiatives and our investments in such initiatives. These statements are based on various assumptions and on the current expectations of management and are not predictions of actual performance, nor are these statements of historical facts. These statements are subject to a number of risks and uncertainties regarding Rimini Street’s business, and actual results may differ materially. These risks and uncertainties include, but are not limited to, the amount and timing of repurchases, if any, under our stock repurchase program and our ability to enhance stockholder value through such program; the impact of our credit facility’s ongoing debt service obligations and financial and operational covenants on our business and related interest rate risk, including uncertainty from the discontinuance of LIBOR and transition to any other interest rate benchmarks; the duration of and operational and financial impacts on our business of the COVID-19 pandemic and related economic impact, as well as the actions taken by governmental authorities, clients or others in response to the continuance of the pandemic; catastrophic events that disrupt our business or that of our current and prospective clients, including terrorism and geopolitical actions specific to an international region; changes in the business environment in which Rimini Street operates, including inflation and interest rates, and general financial, economic, regulatory and political conditions affecting the industry in which Rimini Street operates; adverse developments in pending litigation or any new litigation; our need and ability to raise additional equity or debt financing on favorable terms and our ability to generate cash flows from operations to help fund increased investment in our growth initiatives; the sufficiency of our cash and cash equivalents to meet our liquidity requirements, including under our credit facility; our ability to maintain an effective system of internal control over financial reporting and our ability to remediate any identified material weaknesses in our internal controls; changes in laws and regulations, including changes in tax laws or unfavorable outcomes of tax positions we take, or a failure by us to establish adequate reserves for tax events; competitive product and pricing activity; challenges of managing growth profitably; the customer adoption of our recently introduced products and services, including our Application Management Services (AMS) offerings, in addition to other products and services we expect to introduce in the future; the loss of one or more members of Rimini Street’s management team; our ability to attract and retain qualified personnel; uncertainty as to the long-term value of Rimini Street’s equity securities; the effects of seasonal trends on our results of operations, including the contract renewal cycles for vendor supplied software support and managed services; our ability to prevent unauthorized access to our information technology systems and other cybersecurity threats, protect the confidential information of our employees and clients and comply with privacy and data protection regulations; and those discussed under the headings “Risk Factors” and “Cautionary Note About Forward-Looking Statements” in Rimini Street’s Quarterly Report on Form 10-Q filed on May 4, 2022, and as updated from time to time by Rimini Street’s future Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and other filings by Rimini Street with the Securities and Exchange Commission. In addition, forward-looking statements provide Rimini Street’s expectations, plans or forecasts of future events and views as of the date of this communication. Rimini Street anticipates that subsequent events and developments will cause Rimini Street’s assessments to change. However, while Rimini Street may elect to update these forward-looking statements at some point in the future, Rimini Street specifically disclaims any obligation to do so, except as required by law. These forward-looking statements should not be relied upon as representing Rimini Street’s assessments as of any date subsequent to the date of this communication.


© 2022 Rimini Street, Inc. All rights reserved. “Rimini Street” is a registered trademark of Rimini Street, Inc. in the United States and other countries, and Rimini Street, the Rimini Street logo, and combinations thereof, and other marks marked by TM are trademarks of Rimini Street, Inc. All other trademarks remain the property of their respective owners, and unless otherwise specified, Rimini Street claims no affiliation, endorsement, or association with any such trademark holder or other companies referenced herein.


View source version on businesswire.com: https://www.businesswire.com/news/home/20220525005081/en/


Contacts

Meredith Payette

Rimini Street, Inc.

+1 (312) 515-4736

pr@riministreet.com




Energy Vault Expands in APAC with the Appointment of Lucas Sadler as Vice President of Sales and Business Development, Asia & Pacific

 Based in Australia, Sadler brings 30+ years of sales leadership experience across renewable energy, power generation and energy storage


Sadler, most recently Fluence Energy’s Vice President of Sales for Australia, to lead sales, business development and demand generation in the Asia Pacific region


LUGANO, Switzerland & WESTLAKE VILLAGE, Calif.-Thursday 26 May 2022 [ AETOS Wire ]


(BUSINESS WIRE) -- Energy Vault Holdings, Inc. (NYSE: NRGV) ("Energy Vault"), a leader in sustainable, grid-scale energy storage solutions, today announced the appointment of Lucas Sadler as Vice President of Sales and Business Development, Asia & Pacific (APAC), based in Melbourne, Australia.


Sadler joins Energy Vault with more than 30 years of sales leadership experience across the renewable energy, power generation and energy storage sectors. Immediately prior to joining Energy Vault, he served as Vice President of Sales, Australia and New Zealand, at Fluence Energy Inc. In his role at Energy Vault, Sadler will be responsible for leading sales, business development and demand generation for the company's energy storage software and infrastructure technologies throughout the APAC region. Sadler and his team will focus on building upon Energy Vault's existing presence in the region, which includes Korea Zinc and its subsidiaries Sun Metals and Ark Energy, and BHP in Australia, China Tianying/Atlas Renewable in China, and NTPC in India. Energy Vault is a founding member of the Electric Mine Consortium, an Australia-based group of leading mining companies with the collective ambition to accelerate progress towards the fully electrified zero CO2 and zero particulates mine.


"APAC is a key growth market for Energy Vault as our innovative energy storage technologies are in strong demand for energy and industrial applications as evidenced by our already strong and established presence in the region," said Marco Terruzzin, Chief Product Officer, Energy Vault. "Lucas’ on-the-ground experience in the renewable energy and energy storage sectors in Australia further strengthens our relationships and reach in APAC, where large energy and mining companies have committed to decarbonization. Lucas’ unique and focused experience positions him to best understand local market trends, drive increased demand and further accelerate deployments of our short and long-duration energy storage solutions and software platform. We believe our platform will serve as a critical enabling technology for decarbonization and the energy transition that is taking place throughout the APAC region. We are excited to bring on board a senior leader of Lucas’ caliber to our world-class executive team."


"Energy Vault is bringing innovative energy storage technologies and solutions to market, solving many of the limitations of other storage technologies," said Lucas Sadler, Vice President of Sales and Business Development, Asia & Pacific (APAC), Energy Vault. "The sustainability and circular economic benefits of Energy Vault’s storage systems are truly differentiated, and I believe that its ability to deliver short and long-term duration storage with a hardware-agnostic energy management software platform will provide a competitive advantage for utilities, energy companies and mining companies in APAC, which need energy on demand and for long periods of time to fuel 24/7 operations. Energy Vault has already achieved strong traction in the region and I look forward to further expanding deployment opportunities for the company’s gravity storage and software platform throughout APAC."


Prior to his role at Fluence, Sadler held senior sales, business development and management roles of increasing responsibility, including with Schneider Electric, Powerark Solar, Origin Energy, Yingli Green Energy, EnergyAustralia and Samsung. Sadler has also served as a Director and Board Member of the Australian Solar Council and the Australian Energy Storage Council.


Sadler holds a Global Executive MBA from Monash School of Business - Melbourne, a program composed of three international modules at INSEAD, China Europe International Business School (CEIBS) and NYU Stern School of Business.


About Energy Vault


Energy Vault develops and deploys turnkey sustainable energy storage solutions designed to transform the world’s approach to utility-scale energy storage in realizing decarbonization while maintaining grid resiliency. The company’s proprietary energy management system and optimization software suite is technology agnostic in its ability to orchestrate various generation and energy storage resources to help utilities, independent power producers and large industrial energy users to significantly reduce their levelized cost of energy while maintaining power quality and grid reliability. Energy Vault’s EVx™ gravity-based energy storage system utilizes eco-friendly materials with the ability to integrate waste materials for beneficial re-use. Energy Vault is facilitating the shift to a circular economy while accelerating the clean energy transition for its customers. For additional information, please visit: www.energyvault.com.


Forward-Looking Statements


This press release contains forward-looking statements that involve risks, uncertainties, and assumptions including statements regarding our future expansion, deployments and capabilities. There are a significant number of factors that could cause actual results to differ materially from the statements made in this press release, including: risks related to the rollout of Energy Vault’s business and the timing of expected business milestones in the APAC region, developments and changes in the general market, including with respect to continued interest in de-carbonization in the APAC region, the continuing impact of COVID-19, political, economic, and business conditions, our limited operating history as a public company, and our ability to retain qualified personnel. Additional risks and uncertainties that could affect our financial results are included under the captions "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our Quarterly Report on Form 10-Q for the quarter ended March 31, 2022 filed with the Securities and Exchange Commission (the “SEC”) on May 16, 2022, which is available on our website at investors.energyvault.com and on the SEC's website at www.sec.gov. Additional information will also be set forth in other filings that we make with the SEC from time to time. All forward-looking statements in this press release are based on information available to us as of the date hereof, and we do not assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made, except as required by applicable law.


View source version on businesswire.com: https://www.businesswire.com/news/home/20220526005135/en/


Contacts

Energy Vault Contacts


Investors

energyvaultIR@icrinc.com


Media

media@energyvault.com


AHF: Keeping the Promise to the People of Rwanda

 

(BUSINESS WIRE) -- AIDS Healthcare Foundation (AHF) Rwanda, today reinforced its commitment to promoting access to healthcare services in the country through a two-part donation to the government’s Community-Based Health Insurance (CBHI) scheme. The first tranche of 133,866,000 RFW will support CBHI for 10,822 households with 44,622 beneficiaries, while the second tranche of 22,291,00 RWF will cover CBHI in 1,302 homes. The CBHI scheme, which the government of Rwanda initiated in 2005, increases access to healthcare services and fosters a culture of prevention by alleviating the financial burden of medical costs for many, especially among the poor and vulnerable households.


 “This contribution aligns closely with our mission of providing cutting-edge medicine and advocacy regardless of the ability to pay, and will enable thousands of Rwandans, including our clients, to exercise their right to health, thereby promoting equity in health coverage,” said Dr Lambert Rangira, Country Program Manager, AHF Rwanda. “Our responsibility is to champion better and more cost-effective ways of delivering patient-centred care, which results in healthier, more productive, and more fulfilling lives for our clients.”


Since 2006, in close collaboration with the Ministry of Health and Rwanda Biomedical Centre, AHF Rwanda has provided significant support towards strengthening healthcare services and their delivery in the country, particularly in the HIV/AIDS response. This includes the provision of HIV testing, care and treatment, condom distribution and human resources for health across 29 health facilities in 10 districts: Nyarugenge, Gasabo, Kicukiro, Rwamagana, Kayonza, Nyanza, Huye, Musanze, Nyabihu, and Rubavu; supporting more than 33,000 People Living With HIV.


On the advocacy side, the organisation has championed various initiatives to promote access to healthcare, such as the Vaccinate Our World (VOW) Campaign to address COVID-19 vaccine inequities, the COVID-19 Emergency Relief Fund, and the AHF Grant Fund to strengthen the capacity of CBOs to tackle HIV in communities. Furthermore, its Girls Act Program fosters leadership, confidence and education among young women and girls as essential for preventing HIV, STIs and unplanned Pregnancies. AHF Rwanda is able to achieve all of this by working closely with Civil Society Organisations and the NGO Forum.


“Over the years, we have kept our promise to the government and people of Rwanda as a critical partner in the fight against HIV/AIDS, and we are committed to this collaboration towards Global AIDS Control,” added Dr. Rangira.


About AIDS Healthcare Foundation (AHF)


AIDS Healthcare Foundation, the largest global AIDS organization, currently provides medical care and/or services to over 1.6 million people in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare.


View source version on businesswire.com: https://www.businesswire.com/news/home/20220525006004/en/


Contacts

RWANDA MEDIA CONTACT:

Dr Lambert Rangira,

Country Program Manager

AHF Rwanda

Tel: +250 788358085

Email: Lambert.Rangira@ahf.org


AFRICA BUREAU MEDIA CONTACT:

Oluwakemi Gbadamosi, Director, Advocacy, Policy & Marketing

+234-91-21-500-600

Oluwakemi.gbadamosi@aidshealth.org


US MEDIA CONTACT

Denys Nazarov, Director of Global Policy &

Communications, AHF

+1 323.308.1829

denys.nazarov@ahf.org